Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
10,741.35-177.35
Stock Analysis, IPO, Mutual Funds, Bonds & More

Kotak Emerging Equity Fund: fund review

The time-tested adage says that long-term investors always gain when they buy into good stocks when markets are falling.

, ET Bureau|
Updated: Jul 16, 2019, 11.53 AM IST
0Comments
Getty Images
new investment
The time-tested adage says that long-term investors always gain when they buy into good stocks when markets are falling. Since the time-frame is long-term (at least five years), the gain is enough to make investments worthwhile.

Historically, it has been observed that if long-term investors buy into mid-caps they gain more when compared with large-caps. In the past five years, the BSE Midcap Index has given returns of 58% while the BSE 100 index comprising large companies has given 51% returns. Thus it makes sense to invest in mid-cap schemes with at least a five-year horizon.

Among mid-cap schemes, investors seeking to participate in the rally of quality mid-cap stocks may consider Kotak Emerging Equity Scheme. One of the key features of the scheme is it has beaten its benchmark and peers across all time frames. This consistency is a key attractive proposition for investing in the scheme. The scheme has given 9% and 16 % returns in the past three-year and five-year periods, respectively, while its benchmark index Nifty Midcap 100 TRI has given 7.4 % and 11.6 % in the same periods, respectively.

In the past six months, the scheme’s fund manager Pankaj Tibrewal has constructed a good portfolio of companies which have prominent market share in their respective sectors. A reasonably good market share helps companies tide over slowdown better. Prominent companies which are part of the scheme’s portfolio are V-Guard Industries, Page Industries, Sheela Foam, and Alkem Laboratories.

Portfolio change (past 6 months)
New Entrants Complete Exits Increase in Allocation
Alkem Laboratories D-Link (India) Sheela Foam
Cadila Healthcare Eveready Industries (India) V-Guard Industries
Max Financial Services Sundaram Finance Holdings Torrent Pharma

Returns (in %)
Period CAGR Return SIP CAGR Return Equity market cap
Fund Midcap - Avg
Annualised Return (%)
1 Year -0.60 4.46 -4.48
3 Year 8.91 3.76 7.17
5 Year 16.04 9.69 11.87

Returns peer comparison (in %)
Scheme Name 1-Year 3-Year 5-Year
Axis Midcap Fund 1.78 11.84 12.77
DSP Midcap Fund -0.98 9.19 14.67
HDFC Mid-Cap Opportunities Fund -6.58 8.81 13.64
Source: Accord Fintech, Complied by ETIG Database

Expert Take

Kaustubh Belapurkar, director-Fund Research, Morningstar India
Pankaj Tibrewal runs the fund with a focus on containing downside risk. The fund’s portfolio has been positioned to leverage growth in the domestic economy with its overweight positions in basic materials and industrial stocks. The fund is an excellent option for investors looking invest in the mid-cap space over a medium- to long-term.
0Comments
Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service